EconPapers    
Economics at your fingertips  
 

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice

James F. O’Mahony, Anthony T. Newall and Joost van Rosmalen

Open Access publications from School of Economics, University College Dublin

Abstract: Time is an important aspect of health economic evaluation, as the timing and duration of clinical events, healthcare interventions and their consequences all affect estimated costs and effects. These issues should be reflected in the design of health economic models. This article considers three important aspects of time in modelling: (1) which cohorts to simulate and how far into the future to extend the analysis; (2) the simulation of time, including the difference between discrete-time and continuous-time models, cycle lengths, and converting rates and probabilities; and (3) discounting future costs and effects to their present values. We provide a methodological overview of these issues and make recommendations to help inform both the conduct of cost-effectiveness analyses and the interpretation of their results. For choosing which cohorts to simulate and how many, we suggest analysts carefully assess potential reasons for variation in cost effectiveness between cohorts and the feasibility of subgroup-specific recommendations. For the simulation of time, we recommend using short cycles or continuous-time models to avoid biases and the need for half-cycle corrections, and provide advice on the correct conversion of transition probabilities in state transition models. Finally, for discounting, analysts should not only follow current guidance and report how discounting was conducted, especially in the case of differential discounting, but also seek to develop an understanding of its rationale. Our overall recommendations are that analysts explicitly state and justify their modelling choices regarding time and consider how alternative choices may impact on results.

Keywords: Discount rate; Cycle length; Health economic evaluation; Implementation period; Shared effect (search for similar items in EconPapers)
Pages: 14 pages
Date: 2015-12
References: Add references at CitEc
Citations:

Published in: PharmacoEconomics, 33(12) 2015-12

Downloads: (external link)
http://hdl.handle.net/10197/24957 Open Access version, 2015 (application/pdf)
Our link check indicates that this URL is bad, the error code is: 405 Not Allowed (http://hdl.handle.net/10197/24957 [302 Found]--> https://researchrepository.ucd.ie/handle/10197/24957)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ucn:oapubs:10197/24957

Access Statistics for this paper

More papers in Open Access publications from School of Economics, University College Dublin Contact information at EDIRC.
Bibliographic data for series maintained by UCD School of Economics ().

 
Page updated 2026-11-13
Handle: RePEc:ucn:oapubs:10197/24957